Paper Details

  1. Home
  2. Paper Details

Topical minocycline foam 4%: Results of four phase 1 studies evaluating the potential for phototoxicity, photoallergy, sensitization, and cumulative irritation.

Author: DosikJonathan, EllmanHerman, StuartIain

Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study evaluated the potential for phototoxicity, photoallergy, skin sensitization, and cumulative skin irritation with topical administration of FMX101 4%. It found no evidence of any of these effects, suggesting that FMX101 4% is well-tolerated.
Paper Details　
Original Abstract of the Article :
FMX101 4% contains 4% micronized minocycline (as an HCl) formulated in a lipophilic foam vehicle for topical administration. FMX101 4% has been shown to be an effective and well-tolerated treatment for moderate-to-severe acne in three Phase 3 pivotal studies, however, skin sensitization and toxicity...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/1547691X.2019.1610117

データ提供：米国国立医学図書館（NLM）

Topical Minocycline Foam: Exploring its Safety Profile

The development of new medications is like venturing into an uncharted desert, seeking safe and effective solutions. This research delves into the safety profile of topical minocycline foam 4% (FMX101 4%), a potential treatment for acne. The researchers conducted a series of studies to evaluate the potential for phototoxicity, photoallergy, sensitization, and cumulative skin irritation associated with this topical medication.

Topical Minocycline Foam Demonstrates a Safe Profile

The research indicates that topical minocycline foam 4% exhibits a favorable safety profile. The studies found no evidence of phototoxicity, photoallergy, sensitization, or cumulative skin irritation. This suggests that the medication is well-tolerated and does not pose significant risks of skin irritation or adverse reactions.

Implications for Acne Treatment

This research provides encouraging news for patients seeking safe and effective acne treatments. The study's findings suggest that topical minocycline foam 4% offers a potential therapeutic option without a significant risk of skin irritation or adverse reactions. This research underscores the importance of careful safety evaluations during medication development and the potential for topical minocycline foam to be a valuable tool in treating acne.

Dr. Camel's Conclusion

This research offers a comforting oasis in the desert of acne treatments. Topical minocycline foam 4% appears to be a safe and well-tolerated option, offering a potential therapeutic benefit without the risks of significant skin irritation or adverse reactions. This research underscores the importance of thorough safety evaluations in medication development and encourages further exploration of topical minocycline foam's potential in acne management.

Date :
  1. Date Completed 2020-03-30
  2. Date Revised 2020-03-30
Further Info :

Pubmed ID

31179779

DOI: Digital Object Identifier

10.1080/1547691X.2019.1610117

Related Literature

Article Analysis
・Effects of minocycline topical
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.